Three Baton Rouge-based workers’ comp carriers made the Baton Rouge Business Report’s Top 100 Private Companies list for 2016.
A Houston doctor could face life in prison after a jury convicted him of running a pill mill which included more than 800 patients from Louisiana.
A new DEA intelligence report has found that hundreds of thousands of counterfeit prescription pills, many containing deadly amounts of fentanyl and fentanyl-related compounds, have made their way into the U.S. drug market.
The EEOC has sued Oilfield Instrumentation, U.S.A., Inc., which has an office in Louisiana and operates in the Gulf, for withdrawing a job offer to an applicant because of his diabetes.
NCCI issued the Brexit update to its recent Quarterly Economics Report.
A.M. BestTV addressed the spread of the zika virus and potential workers’ comp implications.
United States Steel Corp. has agreed to rescind its policy of requiring employees to immediately report injuries and illnesses and then punishing employees for failing to abide by the policy.
Ascension and St. James parishes are in the running for a “world-scale” petrochemical complex that ExxonMobil Chemical Co. and the Saudi Basic Industries Corp. are considering building in either Louisiana or Texas.
Optum (a company associated with Helios) will be hosting a continuing education webinar on naloxone tomorrow at noon.
The recent Lafayette Bone & Joint Clinic v. LUBA case decided by the Louisiana Supreme Court sought to settle questions regarding employer choice of pharmacy (about which courts have differed). In the following guest post, Jeffrey Napolitano, attorney with Juge, Napolitano, Guilbeau, Ruli & Frieman representing LUBA in this case, explains the matter and implications for carriers moving forward.